Skip to content
UK Neqas Cardiac Markers
  • Home
  • Scheme Information
  • Register to participate
  • Distribution Dates
  • News
  • Contact Us
UK Neqas Cardiac Markers
Science

Nice Adoption Resorce for Early Rule Out of NTSEMI Using High Sensitivity Troponin

Posted September 26, 2019 Alan Reid

NICE adoption resource for early rule out of NTSEMI using high-sensitivity troponin tests has been published on the NICE website today 26/09/2019: https://www.nice.org.uk/guidance/dg15/resources/adoption-support-resource-insights-from-the-nhs-6905227933/chapter/Introduction

Post navigation

⟵Cardiac Marker Dialogues
UK NEQAS position on BREXIT⟶

Recent Posts

  • Customs Information
  • The Innovation Agency (Academic Health Science Network for the North West Coast):Support available to implement updated NICE Diagnostics Guidance DG40: High Sensitivity troponin tests for the early rule out of NSTEMI
  • UK NEQAS Pan-disciplinary Educational Webinars 2020
  • NT-proBNP Commentary (Distribution 264)
  • HEART Editorial: High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action

Upcoming Events

  1. Distribution 274 – Final Date for Input of Results

    March 26

  2. Distribution 274 – Report Issued (week beginning)

    March 29

  3. Distribution 275 – Distribution Opens

    April 5

View All Events

Get In Touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF
+44 (0)141 440 2888
info@ukneqas-cm.org.uk

MENU

  • My front page
  • Scheme Information
  • Register to participate
  • News
  • Contact Us
  • Privacy Policy

About UKNEQAS

Since 1969 the United Kingdom National External Quality Assessment Service (UK NEQAS) has been providing a comprehensive world-wide service that enables laboratories to fulfil quality goals and facilitate optimal patient care. UK NEQAS now comprises a network of 390 schemes operating from 26 centres based at major hospitals, research institutions and universities throughout the UK.

NHS Greater Glasgow & Clyde, operating UK NEQAS Cardiac Markers, is a UKAS accredited proficiency testing provider (No:8560)(BS EN ISO/IEC 17043:2010). We are a non-profit centre working within NHS Greater Glasgow and Clyde to improve cardiac biomarker investigations in the clinical laboratory sector for the benefit of patients.

Get in touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF
+44 (0)141 440 2888
info@ukneqas-cm.org.uk
©UKNEQAS-Cardiac Markers 2018 | Date last modified February 28, 2021 - 8:58 am